Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Clinical trial NCT06592664 · WITHDRAWN

Trial details

NCT number: NCT06592664
Sponsor: Lisata Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreas Cancer Pancreatic Carcinoma Pancreas Adenocarcinoma Pancreatic Ductal Adenocarcinoma Unresectable Pancreatic Cancer Metastatic Pancreatic Cancer PDAC PDAC - Pancreatic Ductal Adenocarcinoma

Start date: 2030-01-01
Primary completion: 2035-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.